Cite
MLA Citation
JS Smolen et al.. “AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 1322–1323. http://access.bl.uk/ark:/81055/vdc_100135158385.0x000062